metricas
covid
Buscar en
Hipertensión y Riesgo Vascular
Toda la web
Inicio Hipertensión y Riesgo Vascular Estudio PATHWAY-2. La visión del médico de familia en el abordaje de la hipert...
Journal Information
Vol. 33. Issue 4.
Pages 145-149 (October - December 2016)
Share
Share
Download PDF
More article options
Visits
701
Vol. 33. Issue 4.
Pages 145-149 (October - December 2016)
Revisión
Estudio PATHWAY-2. La visión del médico de familia en el abordaje de la hipertensión arterial resistente
PATHWAY-2 study. Vision of the family physician in the approach of resistant hypertension
Visits
701
S. Cinza-Sanjurjo
Corresponding author
C.S. Porto do Son Porto do Son, A Coruña, España
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (1)
Tabla 1. Descenso de presión arterial comparando espironolactona frente a las otras 3 estrategias
Resumen

La hipertensión resistente es una patología relativamente prevalente en atención primaria. Afecta a más del 7% de los pacientes hipertensos atendidos en consultas e implica un elevado riesgo cardiovascular por su alta asociación con episodios cardiovasculares. El estudio PATHWAY-2 ha permitido establecer que la espironolactona es la mejor alternativa posible en cuarta línea de tratamiento para la mayoría de los pacientes, simplificando de forma significativa para el médico de atención primaria el abordaje de estos pacientes.

Palabras clave:
Espironolactona
Hipertensión resistente
Atención primaria
Abstract

Resistant hypertension is a relatively prevalent condition in primary care that exceeds 7% of patients with hypertension assisted in the office and that implies a high cardiovascular risk due to its association with cardiovascular events. The PATHWAY-2 study has allowed to establish that spironolactone is the best possible alternative in the fourth line of treatment for most patients. It significantly simplifies the approach of these patients for primary care physicians.

Keywords:
Sprinolactone
Resistant hypertension
Primary care

Article

These are the options to access the full texts of the publication Hipertensión y Riesgo Vascular
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Hipertensión y Riesgo Vascular

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.hipert.2023.01.001
No mostrar más